References
- CarruthersAKieneKCarruthersJBotulinum A exotoxin use in clinical dermatologyJ Am Acad Dermatol1996345 Pt 17887978632076
- KleinAWCarruthersAFagienSLoweNJComparisons among botulinum toxins: an evidence-based reviewPlast Reconstr Surg20081216413e422e
- American Society for Aesthetic Plastic SurgeryThe American Society for Aesthetic Plastic Surgery Statistics Available from: http://www.surgery.org/media/statisticsAccessed November 9, 2011
- FlynnTCAdvances in the use of botulinum neurotoxins in facial estheticsJ Cosmet Dermatol2012111425022360334
- ImhofMKühneUA Phase III study of incobotulinumtoxinA in the treatment of glabellar frown linesJ Clin Aesthet Dermatol2011410283422010053
- PragerWWissmüllerEKollhorstBWilliamsSZschockeIComparison of two botulinum toxin type A preparations for treating crow’s feet: a split-face, double-blind, proof-of-concept studyDermatol Surg201036Suppl 42155216021134046
- SattlerGCallanderMGrablowitzDNoninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown linesDermatol Surg201036S42146215421134045
- JostWHBlumelJGrafeSBotulinum neurotoxin type A free of complexing proteins (Xeomin) in focal dystoniaDrugs200767566968317385940
- Oliveira de MoraisOMatos Reis-FilhoEVilela PereiraLMartins GomesCAlvesGComparison of four botulinum neurotoxin type A preparations in the treatment of hyperdynamic forehead lines in men: a pilot studyJ Drugs Dermatol201211221621922270205
- BeneckeRJostWHKanovskyPRuzickaEComesGGrafeSA new botulinum toxin type A free of complexing proteins for treatment of cervical dystoniaNeurology200564111949195115955951
- RoggenkämperPJostWHBihariKComesGGrafeSEfficacy and safety of a new Botulinum toxin type A free of complexing proteins in the treatment of blepharospasmJ Neural Transm2006113330331215959841